Ananda Pharma Plc (AQSE:ANA) chief executive Melissa Sturgess has penned an op-ed in The Business of Cannabis’ magazine, entitled ‘The UK risks missing out on the next $1 billion opportunity’.
Here’s an excerpt: “As CEO of Ananda Pharma, I am acutely aware of the immense opportunity we have before us.
“The global cannabis biopharmaceutical market is booming, and the UK is perfectly positioned to lead it.
“We have the scientific expertise, a supportive regulatory framework, and growing patient demand for cannabis-based therapies.”